C, CNS, explained that understanding a patient’s emotional needs can help educate them on treatment adherence.

Hope S. Rugo, MD, FASCO, outlined the top considerations for nurses managing toxicities related to PI3K and AKT inhibitors in ...

Panelists highlight advances in myeloma treatment, focusing on innovative T cell therapies like CAR T and T-cell engagers, ...

Panelists emphasize the importance of multidisciplinary collaboration, patient education, and advocacy in managing multiple ...

Panelists discuss City of Hope’s collaborative partnership with community physicians, emphasizing expert evaluation at ...

Nurses should be familiar with PET scan protocol and what to ask patients with lung and bone cancers before administering ...

Explore essential mental health support strategies for older adults with cancer, addressing grief, community resources, and ...

Given these data, Kirschner, the director of program development at the Cancer Survivorship and Supportive Care Professionals ...

New FDA approvals in July include therapies for NSCLC, relapsed multiple myeloma, liver cancer, and B-cell malignancies.

The addition of retifanlimab to chemotherapy increased progression-free survival in patients with advanced squamous cell ...

Experienced oncology nurses and APPs can help nurses newer to the field understand who is more at risk of opioid addiction, ...

Establishing a routine early in treatment helps proactively manage adverse effects associated with CDK4/6 inhibitors, says ...